FAM110A Antibodies

Santa Cruz Biotechnology delivers a wide array of FAM110A monoclonal antibodies for research focused on understanding FAM110A protein function. FAM110A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FAM110A, a member of the FAM110 family, plays essential roles in cell proliferation and differentiation. FAM110A expression maintains normal cellular function, while its dysregulation has been linked to various diseases, including cancer. Research into FAM110A continues to reveal its potential as a therapeutic target and biomarker. Investigating FAM110A expression patterns can provide valuable insights into disease mechanisms and potential treatment strategies. Understanding FAM110A localization helps researchers map cellular pathways and protein interactions. Exploring FAM110A regulation advances knowledge of cell cycle control and development. Santa Cruz Biotechnology monoclonal antibodies for FAM110A enable researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.